● Recruiting

Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections

Condition: Recurrent Urinary Tract Infection · Sponsor: Helsinki University Central Hospital

PhasePhase 2/Phase 3

Planned participants100

Who can joinFemale, 18 Years to 90 Years

Healthy volunteersYes

About this study

This study investigates Faecal microbiota transplantation (FMT) in prevention of recurrent urinary tract infections (UTIs) caused either by sensitive E. coli or ESBL-E. coli.

This description comes directly from the study's public registry record.

Talk to the study team

Sari Pakkanen, PhD · +358 50 4482769 · vti-tutkimus@hus.fi

Always discuss trial participation with your own doctor first.

Locations (1)

Meilahti Vaccine Research Center, Helsinki University Central Hospital

Helsinki, Finland

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06050148